Galphimia Glauca Pellet
Product Images NDC 0220-2241

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Galphimia Glauca (NDC 0220-2241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boiron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Galgla30c)

Label (Galgla30c)
This is a medication for allergy relief, specifically for itchy nose and sneezing due to hay fever. The medication is in pellet form, containing 0.443 mg of active ingredient per pellet. It should be dissolved under the tongue three times a day until symptoms are relieved or as directed by a doctor. The medication should not be used if the pellet dispenser seal is broken, and if symptoms persist or worsen after 3 days of use, users should consult a doctor. The product is distributed by Boiron Inc. and manufactured in France. Ingredients in the medication are lactose and sucrose. If there are any questions or comments, BoironUSA.com or 1-800-BOIRON-1 can be contacted.*
FDA Label Image

Galphimia 30c Bcp 6916837 02.2022

Galphimia 30c Bcp 6916837 02.2022
The text is not readable and appears to be a combination of random characters. Therefore, the description cannot be generated.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.